Shir-Jing Ho

5PUBLICATIONS
65CO-AUTHORS
Haematological tumoursNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)PharmacogenomicsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur

|Sep 08, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.

Stephen Opat, Alessandra Tedeschi, Bei Hu

|Oct 07, 2022
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma.

Christa Ellen Nath, Andrew Grigg, Sebastian P A Rosser

|Sep 15, 2022
Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients.

Emmanuel J Favaloro, Joanne Clifford, Emma Leitinger

|Aug 13, 2021
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14).

Nizar J Bahlis, Rachid Baz, Simon J Harrison

Pageof 1

Frequent Collaborators

2 joint publications

Eliza A Hawkes

2 joint publications

Stephen Opat

1 joint publications

Emmanuel J Favaloro

1 joint publications

Joanne Clifford